Abbott Laboratories Stock News

The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats.

AbbVie is a top drugmaker that is putting its free cash flow to use lately with a couple of acquisitions. Abbott Labs has a broader, more diverse business that recently generated double-digit growth.

Abbott (ABT) reachead $108.42 at the closing of the latest trading day, reflecting a +0.33% change compared to its last close.

In the closing of the recent trading day, Abbott (ABT) stood at $108.06, denoting a +0.72% change from the preceding trading day.

Abbott's (ABT) EPD business continues to witness low double-digit growth. It has successfully positioned itself as one of the best-positioned large healthcare companies in emerging markets.

With the markets at or near all time highs, after a wild up and down 2023, I could find comfort in one thing, my dividends. As we all know, the market may move up and down irrationally and seemingly o

Abbott (ABT) concluded the recent trading session at $106.68, signifying a +0.43% move from its prior day's close.

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Abbott Labs has a strong brand name and solid growth avenues despite coronavirus-related issues. Intuitive Surgical's dominance in robotic-assisted surgery is an excellent sign for the company's futur

In the closing of the recent trading day, Abbott (ABT) stood at $104.94, denoting a +0.57% change from the preceding trading day.

In 2023, AI and the Magnificent 7 took the lead, leaving non-tech blue chip companies trailing behind in the rearview mirror. Abbott Laboratories had a difficult last three years, with its stock price

Abbott (ABT) closed the most recent trading day at $104.29, moving +0.64% from the previous trading session.

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Investors are optimistic about Abbott (ABT) driven by expansion in the global market and raised guidance.

Abbott Laboratories is a stable investment in challenging times, with an AA- credit rating and a history of surviving economic downturns. ABT has a well-diversified healthcare portfolio, including dia